Page last updated: 2024-10-25

cilostazol and Heritable Pulmonary Arterial Hypertension

cilostazol has been researched along with Heritable Pulmonary Arterial Hypertension in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Cilostazol is a PDE3 inhibitor and used to treat peripheral arterial disease."1.39The effect of cilostazol on right heart function and pulmonary pressure. ( Akgun, T; Alici, G; Alizade, E; Demir, S; Emiroglu, Y; Ozkan, B; Pala, S; Sahin, M; Turkmen, MM; Yazicioglu, MV, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sahin, M1
Alizade, E1
Pala, S1
Alici, G1
Ozkan, B1
Akgun, T1
Emiroglu, Y1
Demir, S1
Yazicioglu, MV1
Turkmen, MM1

Other Studies

1 other study available for cilostazol and Heritable Pulmonary Arterial Hypertension

ArticleYear
The effect of cilostazol on right heart function and pulmonary pressure.
    Cardiovascular therapeutics, 2013, Volume: 31, Issue:6

    Topics: Aged; Cilostazol; Familial Primary Pulmonary Hypertension; Female; Humans; Hypertension, Pulmonary;

2013